Work

Advances in mRNA Cancer Vaccines: Mechanisms, Clinical Progress and Future Outlook

Year: 2026
Type: article
Abstract: Despite significant advances, cancer continues to be a serious burden to the world and the lack of effectiveness of conventional therapies has encouraged the exploration of new immunotherapeutic strategies. mRNA cancer vaccines are one of these that are an attractive approach due to the speed of their design, their high immunogenicity and the potential of personalized treatment. The present review outlines the biology of mRNA cancer vaccines, such as tumor antigens, mechanisms of immune escape and immune activation of the vaccines. Novel developments in lipid nanoparticle (LNP) delivery systems, lymph node targeting strategies, and preclinical development are discussed. In addition, existing clinical data from melanoma, lung cancer, breast cancer, pancreatic cancer, and other cancers are explored, including the exciting results from the KEYNOTE-942 trial. Lastly, key challenges related to tumor heterogeneity, delivery efficiency, manufacturing complexity, and regulatory considerations are analyzed together with future directions involving personalized neoantigen vaccines, AI-driven vaccine design, and next-generation delivery technologies. In conclusion, mRNA cancer vaccines are a rapidly developing field and hold great promise in reshaping the future of precision cancer immunotherapies.
Author: Fengyi Hou
Language: English
Subfield: Immunology
Open Access status: diamond
OpenAlex ID: W7233917213
FWCI:
Cites: 16
Cited by:
Related to: